Data as of 1:39pm ET
| +1.08 / +1.21%|
The 6 analysts offering 12-month price forecasts for GW Pharmaceuticals PLC have a median target of 110.00, with a high estimate of 147.00 and a low estimate of 86.86. The median estimate represents a +22.05% increase from the last price of 90.13.
The current consensus among 6 polled investment analysts is to Buy stock in GW Pharmaceuticals PLC. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.